161 related articles for article (PubMed ID: 3949755)
1. Lipolysis-induced degradation of apolipoproteins B and E of human very low density lipoproteins.
Chung BH; Im JH; Bowdon HR
J Biol Chem; 1986 Feb; 261(6):2960-7. PubMed ID: 3949755
[TBL] [Abstract][Full Text] [Related]
2. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
3. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
[TBL] [Abstract][Full Text] [Related]
4. Lipolytic remnants of human VLDL produced in vitro. Effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants.
Chung BH; Dashti N
J Lipid Res; 2000 Feb; 41(2):285-97. PubMed ID: 10681413
[TBL] [Abstract][Full Text] [Related]
5. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
Evans AJ; Wolfe BM; Strong WL; Huff MW
Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
[TBL] [Abstract][Full Text] [Related]
6. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
Evans AJ; Sawyez CG; Wolfe BM; Huff MW
J Biol Chem; 1992 May; 267(15):10743-51. PubMed ID: 1587849
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Cianflone K; Avramoglu RK; Sawyez C; Huff MW
Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
[TBL] [Abstract][Full Text] [Related]
8. Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis.
Ćwiklińska A; Gliwińska A; Senderowska Z; Kortas-Stempak B; Kuchta A; Dąbkowski K; Jankowski M
Chem Phys Lipids; 2016 Feb; 195():63-70. PubMed ID: 26756862
[TBL] [Abstract][Full Text] [Related]
9. Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitro.
Eisenberg S; Patsch JR; Sparrow JT; Gotto AM; Olivecrona T
J Biol Chem; 1979 Dec; 254(24):12603-8. PubMed ID: 227902
[TBL] [Abstract][Full Text] [Related]
10. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
Murdoch SJ; Breckenridge WC
Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic behavior of apoproteins of human plasma very low density lipoproteins and lipolysis regulation].
Dergunov AD; Shuvaev VV; Perova NV
Biokhimiia; 1990 Jan; 55(1):134-46. PubMed ID: 2160840
[TBL] [Abstract][Full Text] [Related]
13. Lipolysis produces changes in the immunoreactivity and cell reactivity of very low density lipoproteins.
Schonfeld G; Patsch W; Pfleger B; Witztum JL; Weidman SW
J Clin Invest; 1979 Nov; 64(5):1288-97. PubMed ID: 227930
[TBL] [Abstract][Full Text] [Related]
14. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
15. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW
Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926
[TBL] [Abstract][Full Text] [Related]
16. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL.
Keidar S; Kaplan M; Rosenblat M; Brook GJ; Aviram M
Metabolism; 1992 Nov; 41(11):1185-92. PubMed ID: 1435289
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
Huff MW; Breckenridge WC; Strong WL; Wolfe BM
Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
[TBL] [Abstract][Full Text] [Related]
19. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
Sehayek E; Lewin-Velvert U; Chajek-Shaul T; Eisenberg S
J Clin Invest; 1991 Aug; 88(2):553-60. PubMed ID: 1864965
[TBL] [Abstract][Full Text] [Related]
20. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
